News & Update: The Immunobooster Dailytab Gold has demonstrated impressive results in clinical testing, which we are happy to share. Normal, healthy persons and COVID-19 patients with severe symptoms participated in the trials. All patients noted significant improvements in key health metrics and a noticeable decrease in symptoms. It shortened the length of symptoms and was tested even on severe ICU COVID-19 patients. Regards and thanks again.
Published in Business Standard
